Furthermore, a modest increase in NRG1 mRNA levels was observed in the basal-B subgroup (Supplementary Figure S2d,e), while the stratification for clinical breast cancer subtypes highlighted a high variability in the triple-negative subgroup without significant differences with the other subtypes (Supplementary Figure S2f). This evidence concerns the gene NRG1 and breast carcinoma.